3D Medicines Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:3D Medicines Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11066
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
3D Medicines Corp (3D Medicines) is a precision medicine company. The company provides cancer precision medical treatment. It offers cancer diagnosis and treatment through the integration of biological characteristics, clinical diagnosis and treatment, and drug research and development data mining application. 3D Medicines provides precision cancer prevention, precision cancer diagnosis, and precision drug development. The company offers services for different people, which covers tumor tissue and blood samples. It also operates in the field of drug development that covers immunotherapy and other biomarker-Driven targeting therapy. The company has operations in the China, the US and Japan. 3D Medicines is headquartered in Shanghai, China.

3D Medicines Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
3D Medicines Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
3D Medicines Corp, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
China Reform Invests USD101.2 Million in 3D Medicines 10
Partnerships 11
Alphamab Enters into Co-Development Agreement with 3DMed 11
Licensing Agreements 12
3D Medicines Enters into Licensing Agreement with ShangHai HaiHe 12
3D Medicines Corp – Key Competitors 13
3D Medicines Corp – Key Employees 14
3D Medicines Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
3D Medicines Corp, Pharmaceuticals & Healthcare, Key Facts 2
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
3D Medicines Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
3D Medicines Corp, Deals By Therapy Area, 2012 to YTD 2018 8
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
China Reform Invests USD101.2 Million in 3D Medicines 10
Alphamab Enters into Co-Development Agreement with 3DMed 11
3D Medicines Enters into Licensing Agreement with ShangHai HaiHe 12
3D Medicines Corp, Key Competitors 13
3D Medicines Corp, Key Employees 14
3D Medicines Corp, Subsidiaries 15

List of Figures
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
3D Medicines Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[3D Medicines Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tereos:企業の戦略・SWOT・財務分析
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Legal & General Group Plc:戦略・SWOT・企業財務分析
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Acea SpA (ACE):企業の財務・戦略的SWOT分析
    Acea SpA (ACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • Hascol Petroleum Ltd (HASCOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Hascol Petroleum Ltd (Hascol) is a petroleum product distributor. The company offers products such as rocket diesel, gasoline, fuel oil, tiger super and furnace oil, and FUCHS lubricants. Its FUCHS lubricants include corrosion preventives, quenching oils, industrial lube, industrial lube, sp …
  • Heroux-Devtek Inc.:企業の戦略・SWOT・財務情報
    Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CALBEE, Inc. (2229):企業の財務・戦略的SWOT分析
    CALBEE, Inc. (2229) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • EDF Energy Holdings Ltd:電力:M&Aディール及び事業提携情報
    Summary EDF Energy Holdings Ltd (EDF Energy), a subsidiary of Electricite de France SA, is an energy utility and is one of the major producers of low carbon electricity in the UK. The company together with its subsidiaries carries out the generation, provision and supply of electricity and gas. It g …
  • Avesthagen Ltd-医療機器分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • North Eastern Electric Power Corporation Ltd:発電所・企業SWOT分析
    North Eastern Electric Power Corporation Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • China Resources Power Holdings Co Ltd:企業の発電所・SWOT分析2018
    China Resources Power Holdings Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • InFlectis BioScience-製薬・医療分野:企業M&A・提携分析
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that discovers and develops small molecule drugs that target the unfolded protein response (UPR) to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s product lead candidate IFB-088 …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oge Energy Corp
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Celularity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celularity Inc (Celularity) is a biotechnology company that develops and commercializes therapeutics derived from the placenta for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. The company’s pre-clinical and clinical assets include CAR-T cell receptor an …
  • Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • Azarga Metals Corp (AZR):企業の財務・戦略的SWOT分析
    Azarga Metals Corp (AZR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Surgical Care Affiliates LLC (SCAI):企業の財務・戦略的SWOT分析
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆